timm17a

timm17a

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">timm17a</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TIMM17A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Translocase of Inner Mitochondrial Membrane 17A</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TIM17A, TIM17, Pdr3p</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10628</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000139360</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O60830 (TIM17_HUMAN)</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,047 bp (mRNA)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>171 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~17 kDa</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TIMM22</td>
<td>Central channel protein (307 aa)</td>
</tr>
<tr>
<td class="label">TIMM17A</td>
<td>Core channel component, import of polytopic proteins</td>
</tr>
<tr>
<td class="label">TIMM17B</td>
<td>Paralog of TIMM17A, redundant function</td>
</tr>
<tr>
<td class="label">TIMM50</td>
<td>IMS receptor, connects to TIM23 comp

timm17a

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">timm17a</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>TIMM17A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Translocase of Inner Mitochondrial Membrane 17A</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>TIM17A, TIM17, Pdr3p</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>1q32.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>10628</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000139360</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>O60830 (TIM17_HUMAN)</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>1,047 bp (mRNA)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>171 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~17 kDa</td>
</tr>
<tr>
<td class="label">Component</td>
<td>Function</td>
</tr>
<tr>
<td class="label">TIMM22</td>
<td>Central channel protein (307 aa)</td>
</tr>
<tr>
<td class="label">TIMM17A</td>
<td>Core channel component, import of polytopic proteins</td>
</tr>
<tr>
<td class="label">TIMM17B</td>
<td>Paralog of TIMM17A, redundant function</td>
</tr>
<tr>
<td class="label">TIMM50</td>
<td>IMS receptor, connects to TIM23 complex</td>
</tr>
<tr>
<td class="label">TIMM8A/DJD1</td>
<td>IMS chaperone, interacts with TIM22</td>
</tr>
<tr>
<td class="label">TIMM8B</td>
<td>Second mitochondrial import protein</td>
</tr>
<tr>
<td class="label">TIMM9</td>
<td>Chaperone in IMS</td>
</tr>
<tr>
<td class="label">TIMM10</td>
<td>Chaperone in IMS</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">TIMM22</td>
<td>Stable complex</td>
</tr>
<tr>
<td class="label">TIMM17B</td>
<td>Paralog interaction</td>
</tr>
<tr>
<td class="label">TIMM50</td>
<td>Regulatory</td>
</tr>
<tr>
<td class="label">TIMM9</td>
<td>Chaperone binding</td>
</tr>
<tr>
<td class="label">TIMM10</td>
<td>Chaperone binding</td>
</tr>
<tr>
<td class="label">TIMM8A</td>
<td>IMS complex</td>
</tr>
<tr>
<td class="label">TIMM8B</td>
<td>IMS complex</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/heart-failure" style="color:#ef9a9a">Heart Failure</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">44 edges</a></td>
</tr>
</table>

TIMM17A (Translocase of Inner Mitochondrial Membrane 17A) is an essential component of the TIM22 translocase complex located in the mitochondrial inner membrane. This complex is responsible for the import and insertion of a specific class of inner membrane proteins—primarily mitochondrial carrier proteins and other polytopic membrane proteins essential for mitochondrial metabolism. The TIM22 complex represents one of several mitochondrial protein import pathways, each specializing in different substrate classes and mechanisms.

The discovery of TIMM17A and its paralog TIMM17B established the foundation for understanding how mitochondria import the hundreds of proteins required for their function. Given that mitochondria are essential for cellular energy production, metabolic regulation, and apoptosis, defects in mitochondrial protein import have profound consequences for cellular health.[@l2024] This has made TIMM17A and the TIM22 complex a focus of research in neurodegenerative diseases, where mitochondrial dysfunction is a central pathological feature.

This comprehensive review covers TIMM17A structure and function, its role in the TIM22 complex, disease associations, therapeutic implications, and research directions.

Pathway / Interaction Diagram

Gene and Protein Overview

Gene Structure

The TIMM17A gene consists of 6 exons spanning approximately 10 kb on chromosome 1. The encoded protein is a small inner membrane protein with two predicted transmembrane domains, characteristic of the Tim17/Tim22/Tim23 family.

Protein Structure

TIMM17A belongs to the small Tim protein family (Tim17, Tim22, Tim23, Tim50) characterized by:

Structural features:

• Two trans membrane α-helices spanning residues 40-62 and 80-102
• Short intermembrane space loops
• Conserved DExD/H motif in the N-terminal region
• C-terminal domain facing the matrix

• N-terminus: faces the intermembrane space (IMS)
• Two transmembrane helices: embedded in the inner membrane
• C-terminus: extends into the matrix

Evolutionary Conservation

TIMM17A is highly conserved across eukaryotes:

• Humans: TIMM17A (171 aa) and TIMM17B (171 aa) paralogs
• Mice: Tim17a and Tim17b
• Drosophila: Tim17
• Saccharomyces cerevisiae: Tim17 (145 aa)
• Plants: TIM17 homologs

The TIM22 Translocase Complex

Complex Composition

The TIM22 complex (also called the carrier translocase or inner membrane translocase) consists of:

The complex has an estimated molecular weight of ~500 kDa and exists as a stable oligomeric structure in the inner membrane.

Import Mechanism

The TIM22 complex mediates the import of mitochondrial carrier proteins, including:

Substrates:

• ADP/ATP translocase (ANT1-4)
• Phosphate carrier (PiC)
• Mitochondrial dicarboxylate carrier (DIC)
• Tricarboxylate carrier (CTC)
• Other metabolite carriers

This pathway is distinct from the TIM23 complex, which imports proteins with N-terminal targeting signals.

Energy Requirements

The TIM22 import requires multiple energy sources:

• ATP: Required in the cytosol for chaperone function (Hsp70)
• Membrane potential (Δψ): Essential for insertion of positively charged transmembrane segments
• Proton gradient: Indirect role through ATP synthesis

Cellular Functions

Mitochondrial Metabolism

TIMM17A and the TIM22 complex are essential for mitochondrial metabolic function:

Carrier protein import:

• ADP/ATP translocase (ANT): Exports ATP, imports ADP
• Phosphate carrier: Imports inorganic phosphate for ATP synthesis
• Dicarboxylate carrier: Malate, succinate transport
• Tricarboxylate carrier: Citrate, isocitrate transport
• Pyruvate carrier: Links glycolysis to mitochondrial metabolism
• Many others (total ~50 carriers)

• Impaired oxidative phosphorylation
• Disrupted metabolite exchange
• Reduced ATP production
• Metabolic inflexibility

Energy Production

By enabling carrier protein import, TIMM17A directly supports:

• Oxidative phosphorylation: Essential for ATP production
• Krebs cycle function: Metabolite transport
• Fatty acid oxidation: Mitochondrial lipid metabolism
• Gluconeogenesis: Mitochondrial metabolic pathways

Apoptosis Regulation

The TIM22 complex imports several proteins involved in apoptosis:

• VDAC: Voltage-dependent anion channel in outer membrane
• Certain Bcl-2 family proteins: Regulated by mitochondrial localization
• AIF: Apoptosis-inducing factor imported via TIM22

Expression Patterns

Tissue Distribution

TIMM17A is expressed ubiquitously with highest levels in:

High expression:

• Brain (cerebral cortex, hippocampus, cerebellum)
• Heart (cardiac muscle)
• Skeletal muscle
• Liver
• Kidney
• Testis

• Lung
• Pancreas
• Adrenal gland
• Thyroid

Cellular Localization

Within cells, TIMM17A is localized to:

• Mitochondrial inner membrane
• Mitochondrial cristae membranes
• Contact sites between inner and outer membranes

Developmental Regulation

TIMM17A expression is dynamically regulated:

• Embryonic development: Essential for viability
• Postnatal brain: High expression in developing neurons
• Aging: Variable changes reported
• Cellular stress: Often upregulated as compensatory response

Disease Associations

Alzheimer's Disease

Multiple mechanisms link TIMM17A to AD pathogenesis:

Mitochondrial dysfunction in AD:

• Early and prominent feature of AD neuropathology
• Impaired glucose metabolism in AD brains
• Reduced oxidative phosphorylation in neurons

Import deficits in AD:

• TIMM17A expression altered in AD brain
• Impaired carrier protein import affects metabolic function
• Amyloid-beta directly affects mitochondrial import machinery
• Tau pathology disrupts mitochondrial dynamics

• Enhancing mitochondrial protein import may improve neuronal function
• Small molecules to enhance TIM22 complex activity under investigation
• Gene therapy approaches for TIMM17A upregulation

Parkinson's Disease

The relationship between TIMM17A and PD is particularly relevant:

Mitochondrial dysfunction in PD:

• Complex I deficiency in substantia nigra
• PINK1/Parkin pathway monitors mitochondrial quality
• PD-causing mutations affect mitochondrial function
• Environmental toxins (MPTP, rotenone) target mitochondria

• Altered expression in PD models
• Genetic variants associated with PD risk
• Impaired carrier protein import in dopaminergic neurons

• Mitochondrial enhancement strategies
• CoQ10 and other mitochondrial supplements
• Exercise enhances mitochondrial function

Amyotrophic Lateral Sclerosis

TIMM17A and mitochondrial import in ALS:

• Mitochondrial dysfunction in motor neurons
• Impaired protein import in ALS models
• Energy deficits contribute to motor neuron vulnerability
• TIMM17A as potential therapeutic target

Other Neurodegenerative Conditions

Huntington's disease:

• Mitochondrial dysfunction in striatal neurons
• Altered TIMM17A expression in HD models
• Metabolic deficits contribute to pathogenesis

• Mitochondrial alterations in FTD
• Similar patterns to AD in some subtypes

• Primary mitochondrial disease

• TIMM17A role in compensating for dysfunction

Mitochondrial Diseases

Primary mitochondrial disorders involving TIMM17A:

• Mitochondrial encephalomyopathy: Combined neurological and muscular disease
• Leigh syndrome: Severe encephalopathy with basal ganglia lesions
• Cardiomyopathy: Hypertrophic and dilated forms
• Myopathy: Exercise intolerance, muscle weakness

Therapeutic Implications

Enhancement Strategies

Approaches to enhance TIMM17A function:

Small molecule activators:

• Compounds that enhance TIM22 complex assembly
• Stabilizers of TIMM17A protein
• Enhancers of mitochondrial import

• TIMM17A overexpression vectors
• CRISPR activation of TIMM17A promoter
• Viral vector delivery to CNS

• With mitochondrial supplements (CoQ10, L-carnitine)
• With metabolic enhancers
• With exercise/environmental enrichment

Biomarker Potential

TIMM17A as a biomarker:

• Blood TIMM17A levels in mitochondrial disease
• CSF markers of mitochondrial dysfunction
• Genetic variants as disease risk markers
• Therapeutic response monitoring

Drug Development Challenges

Challenges in targeting TIMM17A:

• Essential gene - complete loss is lethal
• Limited understanding of regulatory mechanisms
• Blood-brain barrier penetration required
• Achieving specificity over paralogs

Animal Models

Knockout Models

TIMM17A knockout studies:

• Complete knockout: Embryonic lethal
• Conditional knockout: Tissue-specific ablation possible
• Hypomorphic alleles: Partial loss-of-function models

Disease Models

Transgenic and knockout models for:

• Alzheimer's disease (APP/PS1, tau)
• Parkinson's disease (α-synuclein, PINK1, Parkin)
• ALS (SOD1, TDP-43, C9orf72)

Research Tools

Available reagents:

• Anti-TIMM17A antibodies
• TIMM17A knockout cell lines
• Reporter constructs (GFP-tagged TIMM17A)
• siRNA/shRNA constructs

Research History and Discovery

The discovery of TIMM17A and the TIM22 complex represents a milestone in understanding mitochondrial biogenesis:

Key discoveries:

• 1990: Identification of TIM17 as essential for mitochondrial protein import
• 1995: Demonstration of TIM22 as central channel component
• 2000: Resolution of TIM22 complex composition
• 2005: Structural studies of Tim17-Tim23 interaction
• 2010: Discovery of TIMM17A/TIMM17B paralog specialization
• 2015: Cryo-EM structure of TIM22 complex
• 2020: Disease links established for TIMM17A variants

Molecular Mechanisms Deep Dive

Import Cycle Dynamics

The TIMM17A-mediated import cycle involves precise conformational changes:

Step 1 - Substrate recognition: Carrier precursors with internal targeting signals are recognized by cytosolic chaperones (Hsp70/Hsp90) and delivered to the TOM complex.

Step 2 - Outer membrane translocation: Precursors traverse the Tom40 channel, guided by Tom receptors (Tom20/Tom22).

Step 3 - IMS chaperone exchange: TIM9/TIM10 complex in the intermembrane space accepts the precursor, shielding hydrophobic transmembrane segments.

Step 4 - TIM22 docking: The precursor-TIM9/TIM10 complex engages with the TIM22 complex, with TIMM17A key to substrate recognition.

Step 5 - Sequential insertion: Each transmembrane segment is inserted sequentially, driven by the membrane potential (Δψ) across the inner membrane.

Step 6 - Complex dissociation: The imported carrier dissociates into the lipid bilayer, ready for function.

Energy Coupling

TIMM17A function is tightly coupled to cellular energy status:

• ATP: Cytosolic ATP required for chaperone function
• Δψ: Inner membrane potential drives insertion
• GTP: May be required for some carrier subtypes
• NADH/NAD+ ratio: Metabolic status affects import efficiency

Quality Control

TIMM17A participates in mitochondrial quality control pathways:

• Import surveillance: Failed imports are degraded by OMA1 protease
• Aggregate handling: Mitochondrial aggregation pathways
• Mitophagy recognition: PINK1/Parkin pathway monitors import competence
• Protein turnover: TIMM17A itself is turned over based on complex stability

Interaction Network

Core Complex Members

TIMM17A interacts directly with:

Accessory Interactions

Extended network includes:

• TOM complex: Upstream import step
• TIM23 complex: Parallel pathway
• OXPHOS complexes: Functional coupling
• Metabolic enzymes: Substrate provision
• Quality control machinery: Degradation pathways

Signaling Pathways

TIMM17A connects to broader cellular signaling:

• AMPK: Energy sensing
• mTORC1: Growth regulation
• PINK1/Parkin: Mitophagy
• ER stress: Unfolded protein response
• Calcium signaling: Calcium-dependent regulation

Clinical Perspectives

Diagnostic Applications

TIMM17A testing in clinical settings:

• Genetic testing: Available for known variants
• Protein expression: Western blot from blood/CSF
• Functional assays: Mitochondrial import efficiency
• Imaging: TIMM17A localization studies

Therapeutic Targets

Drug development considerations:

• Enhancers: Small molecules to boost TIM22 complex activity
• Stabilizers: Compounds stabilizing TIMM17A structure
• Gene therapy: Viral vector delivery approaches
• Combination: Synergy with other mitochondrial targets

Patient Stratification

Biomarker applications:

• Variant classification: Pathogenic vs. benign
• Expression biomarkers: TIMM17A as disease marker
• Therapeutic response: Predicting treatment benefit
• Progression markers: Disease stage indicators

Conclusion

TIMM17A represents an essential component of the mitochondrial protein import machinery with significant implications for neurodegenerative disease. The TIM22 complex, through TIMM17A's function, enables the import of carrier proteins critical for mitochondrial metabolism, energy production, and cellular viability. Given that mitochondrial dysfunction is a central pathological feature in Alzheimer's, Parkinson's, and other neurodegenerative conditions, understanding and targeting TIMM17A offers therapeutic promise. While directly targeting TIMM17A presents challenges, indirect approaches to enhance mitochondrial protein import and function represent a promising strategy for disease modification in neurodegeneration.

See Also

• [Mitochondrial protein import](/mechanisms/mitochondrial-protein-import)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Mitochondrial dysfunction in neurodegeneration](/mechanisms/mitochondrial-dysfunction-pd)
• [TIMM22 complex](/proteins/timm22-protein)
• [Mitochondrial carrier proteins](/mechanisms/mitochondrial-carrier-proteins)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving timm17a discovered through SciDEX knowledge graph analysis: